Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “OSTEOPOROSIS, POSTMENOPAUSAL”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00709540
What this trial is testing

A Safety, Tolerability and Pharmacodynamics Study of ACE-011 (ActRIIA-IgG1) in Healthy Postmenopausal Women

Who this might be right for
Osteoporosis
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 40
Not applicableStudy completedNCT02732210
What this trial is testing

Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis

Who this might be right for
Osteoporosis, Age-Related
Amgen 935
Not applicableUnknownNCT03469518
What this trial is testing

Effect of β-cryptoxanthin (β-Cx), Plant Sterols and Galactooligosaccharides on Systemic and Gastrointestinal Markers

Who this might be right for
HypercholesterolemiaOsteoporosisPostmenopausal Disorder
Puerta de Hierro University Hospital 40
Large-scale testing (Phase 3)Study completedNCT00692913
What this trial is testing

Test the Effect of MK0217A on Vitamin D Inadequacy in Postmenopausal Women With Osteoporosis (0217A-262)

Who this might be right for
Osteoporosis
Organon and Co 515
Not applicableUnknownNCT03512743
What this trial is testing

Association of Serum Ferritin and Bone Mineral Density With Bone Metabolism in Chinese Healthy Postmenopausal Women

Who this might be right for
Postmenopausal OsteoporosisIron Metabolism Disorders
Second Affiliated Hospital of Soochow University 1,000
Post-approval studies (Phase 4)WithdrawnNCT03232476
What this trial is testing

Effect of Mechanical Loading With PTH on Cortical Bone

Who this might be right for
Osteoporosis, Postmenopausal
Massachusetts General Hospital
Large-scale testing (Phase 3)Study completedNCT00092079
What this trial is testing

MK0217A and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)

Who this might be right for
OsteoporosisVitamin D Deficiency
Merck Sharp & Dohme LLC 652
Not applicableStudy completedNCT03162068
What this trial is testing

Cushing's Osteoporosis Specificities

Who this might be right for
Osteoporosis in Cushing's SyndromeOsteoporosis in Post-menopausal Women
University Hospital, Clermont-Ferrand 50
Post-approval studies (Phase 4)Study completedNCT00583518
What this trial is testing

STEP: Study of Imaging Techniques (ImaTx and DXA) in Postmenopausal Women With OstEoporosis Using Preotact (FP-008-ES)

Who this might be right for
Postmenopausal Women With Primary Osteoporosis
Nycomed 129
Not applicableStudy completedNCT00698984
What this trial is testing

Investigation of the Effect of BONISTEIN(R) Bone Blend on Bone Mineral Density/Content and Biomarkers of Bone Health

Who this might be right for
Osteoporosis
dsm-firmenich Switzerland AG 70
Large-scale testing (Phase 3)Study completedNCT00172133
What this trial is testing

Open Label Extension Study of PREOS

Who this might be right for
Osteoporosis
Shire 1,683
Large-scale testing (Phase 3)Study completedNCT00859703
What this trial is testing

Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer

Who this might be right for
Breast CancerMenopauseOsteopenia
Hospices Civils de Lyon 20
Testing effectiveness (Phase 2)Study completedNCT00666627
What this trial is testing

Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects

Who this might be right for
Post-menopausal Osteoporosis
Sheffield Teaching Hospitals NHS Foundation Trust 410
Not applicableStudy completedNCT01416194
What this trial is testing

Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)

Who this might be right for
Osteoporosis, Postmenopausal
Pfizer 10,497
Testing effectiveness (Phase 2)Study completedNCT00926380
What this trial is testing

Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis

Who this might be right for
Osteoporosis
Massachusetts General Hospital 94
Not applicableWithdrawnNCT05060380
What this trial is testing

Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis

Who this might be right for
OsteopeniaOsteoporosisPostmenopausal Osteoporosis+1 more
University of Alabama at Birmingham
Early research (Phase 1)Study completedNCT02478879
What this trial is testing

Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen

Who this might be right for
Postmenopausal Osteoporosis
Zosano Pharma Corporation 24
Testing effectiveness (Phase 2)Study completedNCT00620854
What this trial is testing

A Dose Selection Study of Oral Recombinant Salmon Calcitonin (rsCT) in Normal, Healthy, Postmenopausal Women

Who this might be right for
Osteoporosis
Tarsa Therapeutics, Inc. 24
Post-approval studies (Phase 4)Study completedNCT05630768
What this trial is testing

Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women

Who this might be right for
Postmenopausal Osteoporosis
Dong-A ST Co., Ltd. 149
Large-scale testing (Phase 3)Study completedNCT00936897
What this trial is testing

Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates

Who this might be right for
Postmenopausal Osteoporosis
Amgen 833
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation